ZCM
ORGO icon

Zebra Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Zebra Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59,481
Closed -$193K – 79
2022
Q3 		$193K Buy
59,481
+26,853
+82% +$121K 0.73% 58
2022
Q2 		$159K Sell
32,628
-956
-3% -$5.88K 0.47% 80
2022
Q1 		$256K Buy
33,584
+13,846
+70% +$107K 0.59% 68
2021
Q4 		$182K Sell
19,738
-7,276
-27% -$77.3K 0.29% 129
2021
Q3 		$385K Buy
27,014
+234
+0.9% +$3.63K 0.47% 74
2021
Q2 		$445K Sell
26,780
-2,893
-10% -$53.9K 0.52% 71
2021
Q1 		$541K Buy
+29,673
New +$402K 0.6% 61

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Zebra Capital Management's ORGO Position: Q4 2022 in Review

Zebra Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 59,481 shares — an estimated $193K sold.

Zebra Capital Management first reported a position in ORGO in Q1 2021 and held it in 7 quarters. The position peaked at $541K in Q1 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Zebra Capital Management reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Zebra Capital Management sold 59,481 Organogenesis Holdings shares in Q4 2022, an estimated $193K.
  • Zebra Capital Management first reported a position in Organogenesis Holdings in Q1 2021 and held it in 7 quarters.
  • Zebra Capital Management's Organogenesis Holdings position peaked at $541K in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Zebra Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.